LINC-PINT and hepatocellular carcinoma: PINT87aa, encoded by LINC-PINT, has been found to be overexpressed in senescent hepatocellular carcinoma cells and to arrest the cell cycle, induce cellular senescence and inhibit mitochondrial autophagy, providing evidence for is potential use as a therapeutic target for HCC [108].